M. , A. , S. Mdvk, S. Awm, A. Icmje et al., Agree with the manuscript's results and conclusions Wrote the first draft of the paper: MDVK, AWM, SH, AK. Reviewed and edited versions of the manuscript The World Health Organization retains copyright and all other rights in the manuscript of this article as submitted for publication, References 1 Dawood FS, Iuliano AD, Reed C et al. Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study, pp.687-695, 2012.

, Summary of WHO technical consultation: H1N1pdm mortality estimates Available at http://www. who.int/influenza/publications/surveillance_monitoring, pp.25-26, 2011.

, Influenza-like illness in the United States and Mexico Available at http://www.who.int, 2009.

, World Health Organization, situation updates ? pandemic (H1N1), 2009.

, 2009 virus: updated interim WHO guidance on global surveillance World Health Organization, 2009.

, Director-General's opening statement at virtual press conference Available at http://www.who.int/mediacentre, html. 7 WHO. World Health Organization. Situation update pandemic (H1N1), 2009.

J. Ho, A. Ma, and E. , Estimating infection attack rates and severity in real time during an influenza pandemic: analysis of serial cross-sectional serologic surveillance data, PLoS Med, vol.8, 2011.
URL : https://hal.archives-ouvertes.fr/pasteur-00639818

J. Wu, E. Ma, and C. Lee, The Infection Attack Rate and Severity of 2009 Pandemic H1N1 Influenza in Hong Kong, Clinical Infectious Diseases, vol.51, issue.10, pp.1184-1191, 2010.
DOI : 10.1086/656740

M. Kerkhove, T. Asikainen, and N. Becker, Studies Needed to Address Public Health Challenges of the 2009 H1N1 Influenza Pandemic: Insights from Modeling, PLoS Medicine, vol.5, issue.6, p.1000275, 2010.
DOI : 10.1371/journal.pmed.1000275.s007

M. Lipsitch, L. Finelli, R. Heffernan, G. Leung, and S. Redd, Improving the evidence base for decision making during a pandemic: the example of 2009 influenza A/H1N1, H1N1 Surveillance Group 12 WHO. Seroepidemiological studies of pandemic influenza A (H1N1) 2009 virus, pp.89-115229, 2009.

C. , Pandemic influenza A (H1N1) virus infections ? Chicago, Illinois, MMWR Morb Mortal Wkly Rep, vol.58, pp.913-918, 2009.

S. Cauchemez, C. Donnelly, and C. Reed, Household Transmission of 2009 Pandemic Influenza A (H1N1) Virus in the United States, New England Journal of Medicine, vol.361, issue.27, pp.2619-2627, 2009.
DOI : 10.1056/NEJMoa0905498

C. Fraser, C. Donnelly, and S. Cauchemez, Pandemic Potential of a Strain of Influenza A (H1N1): Early Findings, Science, vol.360, issue.25, pp.1557-1561, 2009.
DOI : 10.1056/NEJMoa0903810

K. Laurie, P. Huston, and S. Riley, Influenza serological studies to inform public health action: best practices to optimise timing, quality and reporting, Influenza and Other Respiratory Viruses, vol.73, issue.Suppl 2, 2012.
DOI : 10.1016/S1726-4901(10)70003-4

H. Kelly, H. Peck, K. Laurie, P. Wu, H. Nishiura et al., The agespecific cumulative incidence of infection with pandemic influenza H1N1 2009 was similar in various countries prior to vaccination:e21828. 18 WHO. FLUNET the reporting tool of the global influenza surveillance network, PLoS ONE, vol.6, 2010.

M. Van-kerkhove, K. Vandemaele, and V. Shinde, Risk Factors for Severe Outcomes following 2009 Influenza A (H1N1) Infection: A Global Pooled Analysis, PLoS Medicine, vol.39, issue.Suppl 2, p.1001053, 2011.
DOI : 10.1371/journal.pmed.1001053.s001
URL : https://hal.archives-ouvertes.fr/pasteur-01665262

, United Nations Population Division World population prospects: the 2010 revision, 20 United Nations, 2010.

, Population density (people per sq. km of land area) Available at http://data.worldbank.org/indicator, EN.POP.DNST, 2011.

C. Achonu, R. L. Gubbay, and J. , Seroprevalence of Pandemic Influenza H1N1 in Ontario from January 2009???May 2010, PLoS ONE, vol.6, issue.11, p.26427, 2009.
DOI : 10.1371/journal.pone.0026427.s003

R. Allwinn, J. Geiler, A. Berger, J. Cinatl, and H. Doerr, Determination of serum antibodies against swine-origin influenza A virus H1N1/09 by immunofluorescence, haemagglutination inhibition, and by neutralization tests: how is the prevalence rate of protecting antibodies in humans?, Medical Microbiology and Immunology, vol.29, issue.3, pp.117-121, 2010.
DOI : 10.1016/S0140-6736(09)62026-2

G. Gilbert, M. Cretikos, L. Hueston, G. Doukas, O. Toole et al., Influenza A (H1N1) 2009 Antibodies in Residents of New South Wales, Australia, after the First Pandemic Wave in the 2009 Southern Hemisphere Winter, PLoS ONE, vol.375, issue.9, p.12562, 2010.
DOI : 10.1371/journal.pone.0012562.t004

N. Ikonen, M. Strengell, and L. Kinnunen, High frequency of crossreacting antibodies against 2009 pandemic influenza A(H1N1) virus among the elderly in Finland, Euro Surveill, vol.15, 2010.

C. Rizzo, M. Rota, and A. Bella, Cross-reactive antibody responses to the 2009 A/H1N1v influenza virus in the Italian population in the pre-pandemic period, Vaccine, vol.28, issue.20, pp.3558-3562, 2010.
DOI : 10.1016/j.vaccine.2010.03.006

D. Skowronski, T. Hottes, and J. Mcelhaney, Immuno-epidemiologic Correlates of Pandemic H1N1 Surveillance Observations: Higher Antibody and Lower Cell-Mediated Immune Responses with Advanced Age, Journal of Infectious Diseases, vol.68, issue.2, pp.158-167, 2011.
DOI : 10.1084/jem.180.4.1273

B. Tandale, S. Pawar, and Y. Gurav, Seroepidemiology of pandemic influenza A (H1N1) 2009 virus infections in Pune, India, BMC Infectious Diseases, vol.49, issue.5, p.255, 2010.
DOI : 10.1086/644775

D. Bandaranayake, Q. Huang, A. Bissielo, and T. Wood, Seroprevalence of the 2009 influenza A (H1N1) pandemic in New Zealand, 2010.

A. Bone, J. Guthmann, and A. Assal, Incidence of H1N1 2009 Virus Infection through the Analysis of Paired Plasma Specimens among Blood Donors, France, PLoS ONE, vol.70, issue.6, p.33056, 2012.
DOI : 10.1371/journal.pone.0033056.s001
URL : https://hal.archives-ouvertes.fr/inserm-00722692

S. Dudareva, B. Schweiger, and M. Thamm, Prevalence of Antibodies to 2009 Pandemic Influenza A (H1N1) Virus in German Adult Population in Pre- and Post-Pandemic Period, PLoS ONE, vol.172, issue.6, p.21340, 2011.
DOI : 10.1371/journal.pone.0021340.s005

K. Iwatsuki-horimoto, T. Horimoto, and D. Tamura, ABSTRACT, Clinical and Vaccine Immunology, vol.18, issue.5, pp.860-866, 2011.
DOI : 10.1128/CVI.00428-10

E. Miller, K. Hoschler, P. Hardelid, E. Stanford, N. Andrews et al., Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study, The Lancet, vol.375, issue.9720, pp.1100-1108, 2010.
DOI : 10.1016/S0140-6736(09)62126-7

K. Waalen, A. Kilander, S. Dudman, G. Krogh, T. Aune et al., High prevalence of antibodies to the 2009 pandemic influenza A (H1N1) virus in the Norwegian population following a major epidemic and a large vaccination campaign in autumn 2009, Euro Surveill, vol.15, 2010.

C. Xu, T. Bai, and A. Iuliano, The Seroprevalence of Pandemic Influenza H1N1 (2009) Virus in China, PLoS ONE, vol.49, issue.4, p.17919, 2011.
DOI : 10.1371/journal.pone.0017919.s004

M. Chen, V. Lee, and W. Lim, 2009 Influenza A(H1N1) Seroconversion Rates and Risk Factors Among Distinct Adult Cohorts in Singapore, JAMA, vol.303, issue.14, pp.1383-1391, 2009.
DOI : 10.1001/jama.2010.404

K. Dellagi, O. Rollot, and S. Temmam, Pandemic Influenza Due to pH1N1/2009 Virus: Estimation of Infection Burden in Reunion Island through a Prospective Serosurvey, Austral Winter 2009, PLoS ONE, vol.6, issue.2, p.25738, 2009.
DOI : 10.1371/journal.pone.0025738.t004
URL : https://hal.archives-ouvertes.fr/halsde-00724649

J. Mcvernon, L. K. Nolan, and T. , Seroprevalence of 2009 pandemic influenza A(H1N1) virus in Australian blood donors, Euro Surveill, vol.15, 2009.

C. Reed, J. Katz, K. Hancock, A. Balish, A. Fry et al., Prevalence of Seropositivity to Pandemic Influenza A/H1N1 Virus in the United States following the 2009 Pandemic, PLoS ONE, vol.5, issue.1, p.48187, 2012.
DOI : 10.1371/journal.pone.0048187.s002

S. Soh, A. Cook, and M. Chen, Teacher led school-based surveillance can allow accurate tracking of emerging infectious diseases - evidence from serial cross-sectional surveys of febrile respiratory illness during the H1N1 2009 influenza pandemic in Singapore, BMC Infectious Diseases, vol.11, issue.23, p.336, 2012.
DOI : 10.1186/1471-2334-11-270

P. Hardelid, N. Andrews, and K. Hoschler, Assessment of baseline age-specific antibody prevalence and incidence of infection to novel influenza A H1N1, Health Technol Assess, vol.14, pp.115-192, 2009.

P. Horby, L. Mai, and A. Fox, The Epidemiology of Interpandemic and Pandemic Influenza in Vietnam, 2007???2010, American Journal of Epidemiology, vol.16, issue.3, pp.1062-1074, 2007.
DOI : 10.3201/eid1603.091216

J. Wu, E. Ma, and C. Lee, A serial cross-sectional serologic survey of 2009 Pandemic (H1N1) in Hong Kong: implications for future pandemic influenza surveillance, Influenza Other Respi Viruses, vol.5, pp.190-194, 2011.

C. Cox, K. Goodin, and E. Fisher, Prevalence of 2009 Pandemic Influenza A (H1N1) Virus Antibodies, Tampa Bay Florida ??? November???December, 2009, PLoS ONE, vol.58, issue.12, p.29301, 2009.
DOI : 10.1371/journal.pone.0029301.s003

N. Lapidus, X. De-lamballerie, and N. Salez, Integrative study of pandemic A/H1N1 influenza infections: design and methods of the CoPanFlu-France cohort, BMC Public Health, vol.10, issue.1, p.417, 2012.
DOI : 10.1186/1471-2334-10-301
URL : https://hal.archives-ouvertes.fr/inserm-00730688

. Van-kerkhove, hemagglutination inhibition antibodies against 2009 H1N1 influenza virus in Southern Iran, Iran J Immunol, vol.7, pp.39-48, 2010.

D. Skowronski, T. Hottes, and N. Janjua, Prevalence of seroprotection against the pandemic (H1N1) virus after the 2009 pandemic, Canadian Medical Association Journal, vol.182, issue.17, pp.1851-1856, 2010.
DOI : 10.1503/cmaj.100910
URL : http://www.cmaj.ca/content/182/17/1851.full.pdf

A. Steens, S. Waaijenborg, and P. Teunis, Age-Dependent Patterns of Infection and Severity Explaining the Low Impact of 2009 Influenza A (H1N1): Evidence From Serial Serologic Surveys in the Netherlands, American Journal of Epidemiology, vol.107, issue.2, pp.1307-1315, 2011.
DOI : 10.1073/pnas.0908491107

S. Zimmer, C. Crevar, and D. Carter, Seroprevalence Following the Second Wave of Pandemic 2009 H1N1 Influenza in Pittsburgh, PA, USA, PLoS ONE, vol.324, issue.7, p.11601, 2010.
DOI : 10.1371/journal.pone.0011601.t002
URL : https://doi.org/10.1371/journal.pone.0011601

D. Bandaranayake, Q. Huang, and A. Bissielo, Risk Factors and Immunity in a Nationally Representative Population following the 2009 Influenza A(H1N1) Pandemic, PLoS ONE, vol.7, issue.10, p.13211, 2010.
DOI : 10.1371/journal.pone.0013211.s001
URL : https://doi.org/10.1371/journal.pone.0013211

H. Maltezou, P. Katerelos, and M. Mavrouli, Seroepidemiological study of pandemic influenza H1N1 following the 2009???2010 wave in Greece, Vaccine, vol.29, issue.38, pp.6664-6669, 2011.
DOI : 10.1016/j.vaccine.2011.06.098

C. Chi, C. Liu, and C. Lin, Preexisting Antibody Response against 2009 Pandemic Influenza H1N1 Viruses in the Taiwanese Population, Clinical and Vaccine Immunology, vol.17, issue.12, pp.1958-1962, 2010.
DOI : 10.1128/CVI.00212-10
URL : http://cvi.asm.org/content/17/12/1958.full.pdf

G. Sigmundsdottir, T. Gudnason, and ?. Olafsson, Surveillance of influenza in Iceland during the 2009 pandemic, pii: 19742. 54 Elizondo-Montemayor L, Alvarez MM, Hern ~ A¡ndez-Torre M et al, 2010.
DOI : 10.2807/ese.15.49.19742-en
URL : https://www.eurosurveillance.org/deliver/fulltext/eurosurveillance/15/49/art19742-en.pdf?itemId=/content/10.2807/ese.15.49.19742-en&mimeType=pdf&containerItemId=content/eurosurveillance

. Seroprevalence, among transmission risk groups after the second wave in Mexico, by a virus-free ELISA method, Int J Infect Dis, vol.15, pp.781-786, 2009.

S. Kode, S. Pawar, B. Tandale, S. Parkhi, T. Barde et al., Low Level of Cross-Reactive Antibodies to Pandemic Influenza (H1N1) 2009 Virus in Humans in Pre-Pandemic Period in Maharashtra, India, Indian Journal of Virology, vol.15, issue.5, pp.36-38, 2012.
DOI : 10.3201/eid1511.090685

A. Burmaa, S. Tsatsral, T. Odagiri, A. Suzuki, H. Oshitani et al., Seroconversion rates of Pandemic Influenza A (H1N1) 2009 by a community-based cohort study in Selenghe Province, Mongolia, Influenza Other Respi Viruses, 2012.

S. Riley, K. Kwok, and K. Wu, Epidemiological Characteristics of 2009 (H1N1) Pandemic Influenza Based on Paired Sera from a Longitudinal Community Cohort Study, PLoS Medicine, vol.361, issue.6, p.1000442, 2011.
DOI : 10.1371/journal.pmed.1000442.s009
URL : http://doi.org/10.1371/journal.pmed.1000442

B. Cowling, K. Chan, and V. Fang, Comparative Epidemiology of Pandemic and Seasonal Influenza A in Households, New England Journal of Medicine, vol.362, issue.23, pp.2175-2184, 2010.
DOI : 10.1056/NEJMoa0911530
URL : https://hal.archives-ouvertes.fr/pasteur-00588909

J. Papenburg, M. Baz, and M. Hamelin, Household Transmission of the 2009 Pandemic A/H1N1 Influenza Virus: Elevated Laboratory???Confirmed Secondary Attack Rates and Evidence of Asymptomatic Infections, Clinical Infectious Diseases, vol.51, issue.9, pp.1033-1041, 2010.
DOI : 10.1086/656582

K. Hancock, V. Veguilla, and X. Lu, Cross-Reactive Antibody Responses to the 2009 Pandemic H1N1 Influenza Virus, New England Journal of Medicine, vol.361, issue.20, pp.1945-1952, 2009.
DOI : 10.1056/NEJMoa0906453

N. Verma, M. Dimitrova, and D. Carter, Influenza Virus H1N1pdm09 Infections in the Young and Old: Evidence of Greater Antibody Diversity and Affinity for the Hemagglutinin Globular Head Domain (HA1 Domain) in the Elderly than in Young Adults and Children, Journal of Virology, vol.86, issue.10, pp.5515-5522, 2012.
DOI : 10.1128/JVI.07085-11

I. Stephenson, A. Heath, and D. Major, Reproducibility of Serologic Assays for Influenza Virus A (H5N1), Emerging Infectious Diseases, vol.15, issue.8, pp.1252-1259, 2009.
DOI : 10.3201/eid1508.081754
URL : https://wwwnc.cdc.gov/eid/article/15/8/pdfs/08-1754.pdf

E. Broberg, A. Nicoll, and A. Amato-gauci, Seroprevalence to influenza A (H1N1) 2009 virus where are we? Clin Vaccine, Immunol, vol.18, pp.1205-1212, 2011.
DOI : 10.1128/cvi.05072-11
URL : http://cvi.asm.org/content/18/8/1205.full.pdf

M. Chen, I. Barr, and G. Koh, Serological Response in RT-PCR Confirmed H1N1-2009 Influenza A by Hemagglutination Inhibition and Virus Neutralization Assays: An Observational Study, PLoS ONE, vol.193, issue.8, p.12474, 2010.
DOI : 10.1371/journal.pone.0012474.t003
URL : https://doi.org/10.1371/journal.pone.0012474

V. Veguilla, K. Hancock, and J. Schiffer, Sensitivity and Specificity of Serologic Assays for Detection of Human Infection with 2009 Pandemic H1N1 Virus in U.S. Populations, Journal of Clinical Microbiology, vol.49, issue.6, pp.2210-2215, 2011.
DOI : 10.1128/JCM.00229-11

S. Esposito, C. Daleno, and C. Tagliabue, Antibody response of healthy children to pandemic A/H1N1/2009 influenza virus, Virology Journal, vol.8, issue.1, p.563, 2011.
DOI : 10.1186/1743-422X-8-563

J. Delangue, N. Salez, and L. Ninove, Serological study of the 2009 pandemic due to influenza A H1N1 in the metropolitan French population, Clinical Microbiology and Infection, vol.18, issue.2, pp.177-183, 2012.
DOI : 10.1111/j.1469-0691.2011.03545.x

M. Kerkhove and A. Mounts, 2009 versus 2010 comparison of influenza activity in southern hemisphere temperate countries, Influenza and Other Respiratory Viruses, vol.15, issue.6, pp.375-379, 2009.
DOI : 10.1086/431150

M. Kerkhove, A. Mounts, and S. Mall, Epidemiologic and virologic assessment of the 2009 influenza A (H1N1) pandemic on selected temperate countries in the Southern Hemisphere: Argentina, Australia, Chile, New Zealand and South Africa, Influenza and Other Respiratory Viruses, vol.14, issue.6, pp.487-498, 2011.
DOI : 10.1001/jama.292.11.1333

O. Koita, L. Sangare, and B. Poudiougou, A seroepidemiological study of pandemic A/H1N1(2009) influenza in a rural population of Mali, Clinical Microbiology and Infection, vol.18, issue.10, pp.976-981, 2012.
DOI : 10.1111/j.1469-0691.2011.03725.x

, Appendix: Members of the H1N1pdm Serology Working Group